CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $11,188,000 | -6.2% | 98,976 | -16.9% | 0.32% | -9.7% |
Q1 2017 | $11,922,000 | -6.9% | 119,126 | 0.0% | 0.36% | -3.2% |
Q4 2016 | $12,810,000 | +32.2% | 119,126 | +53.0% | 0.37% | +29.7% |
Q3 2016 | $9,690,000 | -15.2% | 77,882 | -27.2% | 0.29% | -16.9% |
Q2 2016 | $11,423,000 | -6.8% | 107,013 | 0.0% | 0.34% | -9.5% |
Q1 2016 | $12,253,000 | +2.3% | 107,013 | +27.4% | 0.38% | +2.4% |
Q4 2015 | $11,973,000 | +58.7% | 84,000 | 0.0% | 0.37% | +44.4% |
Q3 2015 | $7,545,000 | +227.6% | 84,000 | +320.0% | 0.26% | +262.0% |
Q2 2015 | $2,303,000 | – | 20,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ariose Capital Management Ltd | 88,655 | $10,149,000 | 9.57% |
WARBURG PINCUS LLC | 4,087,200 | $467,903,000 | 8.91% |
RUDMAN ERROL M | 64,001 | $7,327,000 | 4.96% |
INDUS CAPITAL PARTNERS, LLC | 378,518 | $43,333,000 | 4.22% |
OBERWEIS ASSET MANAGEMENT INC/ | 90,105 | $10,315,000 | 2.98% |
Ativo Capital Management LLC | 85,623 | $9,802,000 | 2.66% |
Sensato Investors LLC | 113,296 | $12,970,000 | 2.31% |
Cormorant Asset Management, LP | 111,500 | $12,765,000 | 1.92% |
BARING ASSET MANAGEMENT Ltd | 128,784 | $14,743,000 | 1.23% |
Visium Asset Management, LP | 484,619 | $55,479,000 | 0.94% |